Filing Details

Accession Number:
0001140361-12-021524
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-26 13:16:33
Reporting Period:
2012-04-24
Filing Date:
2012-04-26
Accepted Time:
2012-04-26 13:16:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184151 R Conan Deady One Idexx Drive
Westbrook ME 04092
Corp Vp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-24 2,384 $41.94 19,128 No 4 M Direct
Common Stock Acquisiton 2012-04-24 1,704 $41.94 20,832 No 4 M Direct
Common Stock Acquisiton 2012-04-24 3,773 $34.37 24,605 No 4 M Direct
Common Stock Acquisiton 2012-04-24 3,609 $36.09 28,214 No 4 M Direct
Common Stock Disposition 2012-04-24 14,470 $85.31 13,744 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-04-24 2,384 $0.00 2,384 $41.94
Common Stock Non-Qualfied Stock Option (right to buy) Disposition 2012-04-24 1,704 $0.00 1,704 $41.94
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-04-24 3,773 $0.00 3,773 $34.37
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-04-24 3,609 $0.00 3,609 $53.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-13 No 4 M Direct
0 2014-02-13 No 4 M Direct
4,635 2016-02-13 No 4 M Direct
8,950 2017-02-13 No 4 M Direct
Footnotes
  1. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $85.25 to $85.42, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  2. Grant of options to buy shares of common stock becomes exercisable as to 218 shares on 02/14/2011, and the remaining 2,384 shares on 02/14/2012.
  3. Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009 and 02/14/2010, 3,870 shares on 02/14/2011, and the remaining 1,704 shares on 02/14/2012.
  4. Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.
  5. Grant of options to buy shares of common stock becomes exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.